公司資料
Homology Medicines 股價、新聞與催化劑
- 股票代碼:
- FIXX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
11.90 USD (-1.68%)
收盤價
最後更新: 2026年9月17日
—
市值
股價為何變動
截至 2026年9月17日，FIXX 下跌 1.68%，收於 $11.90。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Homology Medicines was a gene-therapy company focused on genetic medicine before its restructuring and wind-down. Its platform centered on AAV-based delivery and genome repair.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ before restructuring, Homology sat in gene therapy.
商業模式特徵
The company depended on platform validation, clinical data, and the challenge of turning gene therapy into durable value.
生技產業定位
Homology belongs to the historical gene-therapy category rather than the current live public-company set.
未來催化劑
- Homology’s catalysts are gene-editing and ex vivo platform updates, plus any strategic step that shows the company still has a viable path. The market will care about whether the platform can still generate value.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。